Literature DB >> 2178138

Design of an enzymatic hybrid system: a useful strategy for the biosynthesis of benzylpenicillin in vitro.

H Martínez-Blanco1, A Reglero, J Martín-Villacorta, J M Luengo.   

Abstract

A hybrid (prokaryotic-eukaryotic) enzyme system leading to the production of benzylpenicillin has been developed. In vitro synthesis of penicillin G was achieved by incubating 6-aminopenicillanic acid, CoA, phenylacetic acid, homogeneously pure phenylacetyl-CoA ligase (PA-CoA ligase) from Pseudomonas putida and acyl-CoA:6-APA acyltransferase (AT) from Penicillium chrysogenum. Benzylpenicillin was also obtained when AT was coupled with PA-CoA ligase and isopenicillin N-synthetase (IPNS). This is the first description of an in vitro assay that, using enzymes of different microbial origin, mimics the three last enzymatic steps leading to the biosynthesis of penicillin G in P. chrysogenum.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178138     DOI: 10.1111/j.1574-6968.1990.tb03872.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

1.  In vitro enzymatic synthesis of new penicillins containing keto acids as side chains.

Authors:  M A Ferrero; A Reglero; H Martínez-Blanco; M Fernández-Valverde; J M Luengo
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

2.  Purification of Pseudomonas putida acyl coenzyme A ligase active with a range of aliphatic and aromatic substrates.

Authors:  M Fernández-Valverde; A Reglero; H Martinez-Blanco; J M Luengo
Journal:  Appl Environ Microbiol       Date:  1993-04       Impact factor: 4.792

3.  Aerobic catabolism of phenylacetic acid in Pseudomonas putida U: biochemical characterization of a specific phenylacetic acid transport system and formal demonstration that phenylacetyl-coenzyme A is a catabolic intermediate.

Authors:  C Schleissner; E R Olivera; M Fernández-Valverde; J M Luengo
Journal:  J Bacteriol       Date:  1994-12       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.